Repurposing Rafoxanide: From Parasite Killer to Cancer Fighter
Rafoxanide, originally developed as a veterinary anthelmintic for the treatment of parasitic infections in livestock, has recently emerged as a promising therapeutic prospect in oncology. This compound has demonstrated notable antineoplastic effects against a variety of cancers, including skin, gast...
Saved in:
| Main Authors: | Teresa Pacifico, Lorenzo Tomassini, Livia Biancone, Giovanni Monteleone, Carmine Stolfi, Federica Laudisi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-07-01
|
| Series: | Biomedicines |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2227-9059/13/7/1686 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Drug Repurposing for Rare Orphan Diseases Using Machine Learning Techniques
by: Rajesh Manicavasaga, et al.
Published: (2022-05-01) -
Filling the gap in CNS drug development: evaluation of the role of drug repurposing
by: A. Caban, et al.
Published: (2017-01-01) -
Repurposing drugs: Lessons from rheumatology in the COVID-19 pandemic
by: Manesh Manoj, et al.
Published: (2021-01-01) -
Discovery of a novel polymyxin adjuvant against multidrug-resistant gram-negative bacteria through oxidative stress modulation
by: Taotao Lu, et al.
Published: (2025-03-01) -
Quantification of Rafoxanide Drug Residue from Sheep Meat in Sulaymaniyah Province/Iraq Using High-Performance Liquid Chromatography Hplc-Uv
by: Hiwa Husein, et al.
Published: (2023-09-01)